title: Reply to Dr Grzybowski.
authors.affiliation: Eye Research Center, Iran University of Medical Sciences, Tehran, Iran.
authors.forename: K G
authors.initials: KG
authors.lastname: Falavarjani
authors.affiliation: Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA.
authors.forename: Q D
authors.initials: QD
authors.lastname: Nguyen
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D006801:Humans; D058449:Intravitreal Injections / Q000009:adverse effects*; D012164:Retinal Diseases / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A